Carmen Stanca is a Gastroenterology physician affiliated with NYU Langone Health. OpenAlex indexes 48 publications with 1,848 citations (h-index 19).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
530 1st Ave Ste 4j
New York, NY 100166402
Telephone
212-263-3643Provider last certified this registry record 19 Jun 2023.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20252 payments
- Gilead Sciences, Inc.Program year20251 payment
- Ipsen Biopharmaceuticals, IncProgram year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
55%Bile Acid19.4%Ursodiol100%Part D≥24 patientsOsmotic Laxative10.3%Constulose50%Lactulose50%Part D<11 patients+ 4 more classes in this area
Cancer & immunology
16%Calcineurin inhibitor11.1%Tacrolimus72%Cyclosporine Modified28%Part D<11 patientsPurine Antimetabolite4.8%Azathioprine100%Part D<11 patientsAnti-infectives
14.2%Nucleoside and nucleotide reverse transcriptase inhibitors10%Vemlidy100%Part D<11 patientsHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor4.3%Entecavir100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis
Digestive Diseases and Sciences
2022 - Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications
The American Journal of Gastroenterology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Harvey Pass, MD
NYU Langone Health
Gareth Morgan, MD
NYU Langone Health
Douglas Kondziolka, MD
NYU Langone Health
Nathan Levin, MD
NYU Langone Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”